SEMIZLIK BILAN OG‘RIGAN BEMORLARDA ICHAK MIKROFLORASI TARKIBIGA "BAJANA" PREPARATI BILAN MIKROBIOTANI KOMPLEKS KORREKSIYALASHNING TA’SIRI
##article.subject##:
semizlik, ichak mikrobiotasi, prebiotiklar, probiotiklar.##article.abstract##
So’nggi tadqiqotlar natijalariga ko’ra, semizlik mikroblarning xilma-xilligi kamayishi va mikrobiotaning turlar bo’yicha boyligi pasayishi bilan bog’liq. Tadqiqot olib borilib, ikki guruh: asosiy guruh - 60 nafar semiz bemor va nazorat guruhi - 25 nafar normal vaznli bemor kiritildi. Semizlik guruhida Lactobacillus spp pasayish tendentsiyasi qayd etildi. и Bifidobacterium spp. Shuningdek, yallig’lanishga qarshi salohiyatga ega bo’lgan va butiratlarning asosiy mahsuloti bo’lgan Faecalibacterium prausnitzii (p = 0,030) miqdori ishonchli ravishda kamaytirildi.
Библиографические ссылки
Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027–1031. DOI: 10.1038/nature05414.
Qin J., Li Y., Cai Z., Li S., Zhu J., Zhang F., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55–60. DOI: 10.1038/nature11450.
Karlsson F.H., Tremaroli V., Nookaew I., Bergström G., Behre C.J., Fagerberg B., et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498(7452):99–103. DOI: 10.1038/nature12198.
Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–214. DOI: 10.1038/nature11234.
Cani P.D. Human gut microbiome: hopes, threats and promises. Gut. 2018;67(9):1716–1725. DOI: 10.1136/gutjnl-2018-316723.
Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444(7122):1022–1023. DOI: 10.1038/4441022a.
Tilg H., Moschen A.R. Microbiota and diabetes: an evolving relationship. Gut. 2014;63(9):1513–1521. DOI: 10.1136/gutjnl-2013-306144.
Le Chatelier E., Nielsen T., Qin J., Prifti E., Hildebrand F., Falony G., et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500(7464):541–546. DOI: 10.1038/nature12506.
Derrien M., van Hylckama Vlieg J.E. Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends Microbiol. 2015;23(6):354–366. DOI: 10.1016/j.tim.2015.03.002.
Zeevi D., Korem T., Zmora N., Israeli D., Rothschild D., Weinberger A., et al. Personalized nutrition by prediction of glycemic responses. Cell. 2015;163(5):1079–1094. DOI: 10.1016/j.cell.2015.11.001.
Blaut M., Clavel T. Metabolic diversity of the intestinal microbiota: implications for health and disease. J Nutr. 2007;137(3 Suppl 2):751S–755S. DOI: 10.1093/jn/137.3.751S.
Kootte R.S., Levin E., Salojärvi J., Smits L.P., Hartstra A.V., Udayappan S.D., et al. Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition. Cell Metab. 2017;26(4):611–619.e6. DOI: 10.1016/j.cmet.2017.09.008.
